Pathstone Family Office, LLC Fibrogen Inc Transaction History

Pathstone Family Office, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $31 - $55	-1 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $1,661 - $2,184	-51 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$23.3 - $45.96 $1,188 - $2,343	51 New	51 $2,000
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $2,248 - $3,553	-64 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $2,430 - $3,850	64 New	64 $3,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.